83 related articles for article (PubMed ID: 10958862)
1. Diagnostic usefulness of tumour marker levels in pleural effusions of malignant and benign origin.
Kuralay F; Tokgöz Z; Cömlekci A
Clin Chim Acta; 2000 Oct; 300(1-2):43-55. PubMed ID: 10958862
[TBL] [Abstract][Full Text] [Related]
2. IR808@MnO nano-near infrared fluorescent dye's diagnostic value for malignant pleural effusion.
Wang X; Yan X; Zhang Z; Xu C; Du F; Xie Y; Yin X; Lei Z; Jiang Y; Yang W; Zhou X; Wang Y
Respir Res; 2024 Jan; 25(1):22. PubMed ID: 38195540
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic flowchart for tuberculous pleurisy, pleural infection, and malignant pleural effusion.
Shimoda M; Tanaka Y; Morimoto K; Yoshiyama T; Yoshimori K; Ohta K
Respir Investig; 2024 Jan; 62(1):157-163. PubMed ID: 38141528
[TBL] [Abstract][Full Text] [Related]
4. Morphological markers of chromosomal instability as predictors of malignancy in pleural effusion.
Aggarwal P; Handa U; Bhagat R; Aggarwal D
Diagn Cytopathol; 2024 Feb; 52(2):76-81. PubMed ID: 37946685
[TBL] [Abstract][Full Text] [Related]
5. A PET-CT score for discriminating malignant from benign pleural effusions.
Simó M; Persiva O; Sánchez L; Montoro B; Vázquez A; Sansano I; Alemán C
Med Clin (Barc); 2023 Nov; 161(10):422-428. PubMed ID: 37487808
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Utility of Claudin4 and Comparison with BerEp4 as a Marker for Metastatic Adenocarcinoma in Serous Effusions.
Mangla G; Bakshi P; Agarwal P; Verma K
Acta Cytol; 2023; 67(5):564-572. PubMed ID: 37331346
[TBL] [Abstract][Full Text] [Related]
7. Use of tumor markers in distinguishing lung adenocarcinoma-associated malignant pleural effusion from tuberculous pleural effusion.
Ai L; Wang W; Li J; Ye T; Li Y
Am J Med Sci; 2024 Apr; ():. PubMed ID: 38583522
[TBL] [Abstract][Full Text] [Related]
8. CAMPO Precision128 Max ENERGY Spectrum CT Combined with Multiple Parameters to Evaluate the Benign and Malignant Pleural Effusion.
Zhang T; Wu C; Li Z; Ding Y; Wen L; Wang L
J Healthc Eng; 2021; 2021():5526977. PubMed ID: 33728032
[TBL] [Abstract][Full Text] [Related]
9. Claudin-4 immunocytochemistry is specific and sensitive for the diagnosis of malignant carcinomatous effusions: Results from a pilot study.
Hruaii V; Thirunavukkarasu B; Prabha V; Mathur S; Iyer VK; Nambirajan A; Jain D
Diagn Cytopathol; 2024 Jan; 52(1):30-41. PubMed ID: 37837242
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies against p53 are not increased in human ascites and pleural effusions.
Munker R; Stötzer O; Darsow M; Classen S; Lebeau A; Wilmanns W
Cancer Immunol Immunother; 1996 Mar; 42(3):200-1. PubMed ID: 8640849
[TBL] [Abstract][Full Text] [Related]
11. Natural antibodies targeting LPS in pleural effusions of various etiologies.
Sarrigeorgiou I; Rouka E; Kotsiou OS; Perlepe G; Gerovasileiou ES; Gourgoulianis KI; Lymberi P; Zarogiannis SG
Am J Physiol Lung Cell Mol Physiol; 2024 Jun; 326(6):L727-L735. PubMed ID: 38591123
[TBL] [Abstract][Full Text] [Related]
12. Association of serum tumor markers with serous effusion in systemic lupus erythematosus.
Zhong Y; Ma J; Zhang L; Liu Z; Xue L
Heliyon; 2023 Dec; 9(12):e23213. PubMed ID: 38144302
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of vascular endothelial growth factor-A, -C and -D for the diagnosis and prognosis of cancer patients with malignant effusions.
Jia L; DU Y; Li T; Lv Y; Wang Y; Zhang Y; Zhou X; Liu W
Oncol Lett; 2015 Aug; 10(2):667-674. PubMed ID: 26622551
[TBL] [Abstract][Full Text] [Related]
14. Clinical identification of malignant pleural effusions.
Jia J; Marazioti A; Voulgaridis A; Psallidas I; Lamort AS; Iliopoulou M; Krontira AC; Lilis I; Asciak R; Kanellakis NI; Rahman NM; Karkoulias K; Spiropoulos K; Liu R; Kaiser JC; Stathopoulos GT
Transl Oncol; 2024 Jan; 39():101800. PubMed ID: 37839174
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometry in the detection of circulating tumor cells in neoplastic effusions.
Gostomczyk K; Łukaszewska E; Borowczak J; Bator A; Zdrenka M; Bodnar M; Szylberg Ł
Clin Chim Acta; 2024 Jan; 552():117651. PubMed ID: 37980974
[TBL] [Abstract][Full Text] [Related]
16. A Combination of Ultrasound Characteristics with Macroscopic and Biochemical Features to Diagnose the Etiology of Lymphocytic Pleural Effusions.
Piskac Zivkovic N; Cvetko D; Zivkovic M; Simac B; Zelenika Margeta M; Kovacevic I; Malnar Janes L; Lalic K; Guzvinec Z; Ljilja Posavec A; Feljan H; Vergles M; Kuster Z
Diagnostics (Basel); 2023 Nov; 13(23):. PubMed ID: 38066743
[TBL] [Abstract][Full Text] [Related]
17. Ferritin assay in malignant pleural effusion.
Chung WT; Lee JH; Park JG; Sohn GI; Park SK; Shin YK
Korean J Intern Med; 1987 Jan; 2(1):106-11. PubMed ID: 3154810
[TBL] [Abstract][Full Text] [Related]
18. Secretome of pleural effusions associated with non-small cell lung cancer (NSCLC) and malignant mesothelioma: therapeutic implications.
Donnenberg AD; Luketich JD; Donnenberg VS
Oncotarget; 2019 Nov; 10(60):6456-6465. PubMed ID: 31741710
[TBL] [Abstract][Full Text] [Related]
19. Cancer antigen-125 levels correlate with pleural effusions and COPD-related complications in people living at high altitude.
Li S; Ma H; Gan L; Ma X; Wu S; Li M; Tang CH; Tsai HC
Medicine (Baltimore); 2018 Nov; 97(46):e12993. PubMed ID: 30431573
[TBL] [Abstract][Full Text] [Related]
20. Transcriptional profiling of single tumour cells from pleural effusions reveals heterogeneity of epithelial to mesenchymal transition and extra-cellular matrix marker expression.
Sen M; Hausler RM; Dulmage K; Black TA; Murphy W; Pletcher CH; Wang L; Chen C; Yee SS; Bornheimer SJ; Maxwell KN; Stanger BZ; Moore JS; Thompson JC; Carpenter EL
Clin Transl Med; 2022 Jul; 12(7):e888. PubMed ID: 35811459
[No Abstract] [Full Text] [Related]
[Next] [New Search]
